vs
通用电气医疗（GEHC）与MASTEC INC（MTZ）财务数据对比。点击上方公司名可切换其他公司
通用电气医疗的季度营收约是MASTEC INC的1.4倍（$5.7B vs $3.9B），通用电气医疗净利率更高（10.3% vs 3.6%，领先6.7%），MASTEC INC同比增速更快（15.8% vs 7.1%），过去两年MASTEC INC的营收复合增速更高（21.1% vs 10.7%）
通用电气医疗是总部位于美国伊利诺伊州芝加哥的医疗科技企业，旗下设四大业务板块：医学影像（含分子成像、CT、核磁共振、女性健康筛查、X射线系统）、超声、患者护理解决方案（聚焦远程患者监测、麻醉呼吸护理、心脏病诊断、婴幼儿照护）及制药诊断业务。
MasTec Inc是总部位于美国佛罗里达州科勒尔盖布尔斯的基础设施工程建设企业，面向能源、公用事业及通信领域提供基础设施的设计、施工、安装、运维与升级服务，客户主要来自公用事业、通信及政府行业。
GEHC vs MTZ — 直观对比
营收规模更大
GEHC
是对方的1.4倍
$3.9B
营收增速更快
MTZ
高出8.7%
7.1%
净利率更高
GEHC
高出6.7%
3.6%
两年增速更快
MTZ
近两年复合增速
10.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $5.7B | $3.9B |
| 净利润 | $588.0M | $142.7M |
| 毛利率 | 39.7% | — |
| 营业利润率 | 14.5% | 4.4% |
| 净利率 | 10.3% | 3.6% |
| 营收同比 | 7.1% | 15.8% |
| 净利润同比 | -18.4% | 90.9% |
| 每股收益（稀释后） | $1.28 | $1.81 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GEHCMTZ
| Q4 25 | $5.7B | $3.9B | ||
| Q3 25 | $5.1B | $4.0B | ||
| Q2 25 | $5.0B | $3.5B | ||
| Q1 25 | $4.8B | $2.8B | ||
| Q4 24 | $5.3B | $3.4B | ||
| Q3 24 | $4.9B | $3.3B | ||
| Q2 24 | $4.8B | $3.0B | ||
| Q1 24 | $4.7B | $2.7B |
净利润GEHCMTZ
| Q4 25 | $588.0M | $142.7M | ||
| Q3 25 | $446.0M | $160.7M | ||
| Q2 25 | $486.0M | $85.8M | ||
| Q1 25 | $564.0M | $9.9M | ||
| Q4 24 | $721.0M | $74.7M | ||
| Q3 24 | $470.0M | $95.2M | ||
| Q2 24 | $428.0M | $34.0M | ||
| Q1 24 | $374.0M | $-41.2M |
毛利率GEHCMTZ
| Q4 25 | 39.7% | — | ||
| Q3 25 | 38.7% | — | ||
| Q2 25 | 39.6% | — | ||
| Q1 25 | 42.1% | — | ||
| Q4 24 | 42.8% | — | ||
| Q3 24 | 41.7% | — | ||
| Q2 24 | 41.4% | — | ||
| Q1 24 | 40.9% | — |
营业利润率GEHCMTZ
| Q4 25 | 14.5% | 4.4% | ||
| Q3 25 | 12.7% | 5.3% | ||
| Q2 25 | 13.1% | 3.4% | ||
| Q1 25 | 13.2% | 0.3% | ||
| Q4 24 | 15.1% | 2.8% | ||
| Q3 24 | 13.9% | 4.2% | ||
| Q2 24 | 12.6% | 2.1% | ||
| Q1 24 | 11.6% | -1.7% |
净利率GEHCMTZ
| Q4 25 | 10.3% | 3.6% | ||
| Q3 25 | 8.7% | 4.0% | ||
| Q2 25 | 9.7% | 2.4% | ||
| Q1 25 | 11.8% | 0.3% | ||
| Q4 24 | 13.6% | 2.2% | ||
| Q3 24 | 9.7% | 2.9% | ||
| Q2 24 | 8.8% | 1.1% | ||
| Q1 24 | 8.0% | -1.5% |
每股收益（稀释后）GEHCMTZ
| Q4 25 | $1.28 | $1.81 | ||
| Q3 25 | $0.98 | $2.04 | ||
| Q2 25 | $1.06 | $1.09 | ||
| Q1 25 | $1.23 | $0.13 | ||
| Q4 24 | $1.58 | $0.95 | ||
| Q3 24 | $1.02 | $1.21 | ||
| Q2 24 | $0.93 | $0.43 | ||
| Q1 24 | $0.81 | $-0.53 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.5B | $396.0M |
| 总债务越低越好 | $10.0B | $2.2B |
| 股东权益账面价值 | $10.4B | $3.3B |
| 总资产 | $36.9B | $9.9B |
| 负债/权益比越低杠杆越低 | 0.96× | 0.67× |
8季度趋势，按日历期对齐
现金及短期投资GEHCMTZ
| Q4 25 | $4.5B | $396.0M | ||
| Q3 25 | $4.0B | $231.4M | ||
| Q2 25 | $3.7B | $191.1M | ||
| Q1 25 | $2.5B | $345.7M | ||
| Q4 24 | $2.9B | $399.9M | ||
| Q3 24 | $3.5B | $181.2M | ||
| Q2 24 | $2.0B | $297.6M | ||
| Q1 24 | $2.6B | $249.3M |
总债务GEHCMTZ
| Q4 25 | $10.0B | $2.2B | ||
| Q3 25 | $10.3B | $2.2B | ||
| Q2 25 | $10.3B | $2.1B | ||
| Q1 25 | $8.8B | $2.0B | ||
| Q4 24 | $9.0B | $2.0B | ||
| Q3 24 | $10.3B | $2.1B | ||
| Q2 24 | $9.2B | $2.4B | ||
| Q1 24 | $9.3B | $2.5B |
股东权益GEHCMTZ
| Q4 25 | $10.4B | $3.3B | ||
| Q3 25 | $10.0B | $3.1B | ||
| Q2 25 | $9.7B | $2.9B | ||
| Q1 25 | $9.2B | $2.9B | ||
| Q4 24 | $8.4B | $2.9B | ||
| Q3 24 | $8.3B | $2.8B | ||
| Q2 24 | $7.8B | $2.7B | ||
| Q1 24 | $7.4B | $2.7B |
总资产GEHCMTZ
| Q4 25 | $36.9B | $9.9B | ||
| Q3 25 | $36.1B | $9.7B | ||
| Q2 25 | $35.5B | $9.1B | ||
| Q1 25 | $33.6B | $8.9B | ||
| Q4 24 | $33.1B | $9.0B | ||
| Q3 24 | $33.9B | $8.8B | ||
| Q2 24 | $31.9B | $8.7B | ||
| Q1 24 | $32.2B | $8.7B |
负债/权益比GEHCMTZ
| Q4 25 | 0.96× | 0.67× | ||
| Q3 25 | 1.03× | 0.71× | ||
| Q2 25 | 1.06× | 0.71× | ||
| Q1 25 | 0.95× | 0.71× | ||
| Q4 24 | 1.06× | 0.70× | ||
| Q3 24 | 1.24× | 0.76× | ||
| Q2 24 | 1.18× | 0.87× | ||
| Q1 24 | 1.25× | 0.95× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $372.7M |
| 自由现金流经营现金流 - 资本支出 | — | $292.5M |
| 自由现金流率自由现金流/营收 | — | 7.4% |
| 资本支出强度资本支出/营收 | 2.4% | 2.0% |
| 现金转化率经营现金流/净利润 | — | 2.61× |
| 过去12个月自由现金流最近4个季度 | — | $285.7M |
8季度趋势，按日历期对齐
经营现金流GEHCMTZ
| Q4 25 | — | $372.7M | ||
| Q3 25 | — | $89.0M | ||
| Q2 25 | $94.0M | $5.6M | ||
| Q1 25 | $250.0M | $78.4M | ||
| Q4 24 | — | $471.7M | ||
| Q3 24 | — | $277.7M | ||
| Q2 24 | $-119.0M | $264.4M | ||
| Q1 24 | $419.0M | $107.8M |
自由现金流GEHCMTZ
| Q4 25 | — | $292.5M | ||
| Q3 25 | — | $20.3M | ||
| Q2 25 | $8.0M | $-58.2M | ||
| Q1 25 | $98.0M | $31.1M | ||
| Q4 24 | — | $423.4M | ||
| Q3 24 | — | $234.1M | ||
| Q2 24 | $-183.0M | $232.9M | ||
| Q1 24 | $274.0M | $82.3M |
自由现金流率GEHCMTZ
| Q4 25 | — | 7.4% | ||
| Q3 25 | — | 0.5% | ||
| Q2 25 | 0.2% | -1.6% | ||
| Q1 25 | 2.1% | 1.1% | ||
| Q4 24 | — | 12.4% | ||
| Q3 24 | — | 7.2% | ||
| Q2 24 | -3.8% | 7.9% | ||
| Q1 24 | 5.9% | 3.1% |
资本支出强度GEHCMTZ
| Q4 25 | 2.4% | 2.0% | ||
| Q3 25 | 2.1% | 1.7% | ||
| Q2 25 | 1.7% | 1.8% | ||
| Q1 25 | 3.2% | 1.7% | ||
| Q4 24 | 1.9% | 1.4% | ||
| Q3 24 | 1.9% | 1.3% | ||
| Q2 24 | 1.3% | 1.1% | ||
| Q1 24 | 3.1% | 0.9% |
现金转化率GEHCMTZ
| Q4 25 | — | 2.61× | ||
| Q3 25 | — | 0.55× | ||
| Q2 25 | 0.19× | 0.07× | ||
| Q1 25 | 0.44× | 7.91× | ||
| Q4 24 | — | 6.31× | ||
| Q3 24 | — | 2.92× | ||
| Q2 24 | -0.28× | 7.78× | ||
| Q1 24 | 1.12× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GEHC
| Imaging Segment | $2.6B | 45% |
| PCS Segment | $824.0M | 14% |
| P Dx Segment | $790.0M | 14% |
| Specialized Ultrasound Subsegment | $735.0M | 13% |
| Monitoring Solutions Subsegment | $578.0M | 10% |
| Life Support Solutions Subsegment | $247.0M | 4% |
MTZ
| Clean Energy And Infrastructure | $1.3B | 33% |
| Power Delivery | $1.1B | 28% |
| Communications | $906.7M | 23% |
| Pipeline Infrastructure | $643.8M | 16% |
